Related Experiment Video

Updated: Jul 8, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Epidemiology and clinical significance of pneumocystis colonization

Alison Morris1, Kenneth Wei, Kamyar Afshar

  • 1Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. morrisa@upmc.edu

The Journal of Infectious Diseases
|January 4, 2008
PubMed

Insights

Pneumocystis colonization, detected via sensitive methods, may indicate lung inflammation and disease risk in various populations. This review explores its occurrence, risk factors, and clinical significance.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Pneumocystis pneumonia is a significant cause of illness and death in immunocompromised individuals, especially those with HIV.
  • Pneumocystis colonization, distinct from pneumonia, is increasingly recognized as a clinically relevant phenomenon.
  • Molecular techniques like PCR are vital for detecting Pneumocystis colonization.

Purpose of the Study:

  • To review the evidence for Pneumocystis colonization in animals and humans.
  • To examine the epidemiology and risk factors associated with Pneumocystis colonization.
  • To evaluate the clinical significance and lung disease associations of Pneumocystis colonization.

Main Methods:

  • Literature review of studies on Pneumocystis colonization.
  • Analysis of epidemiological data and risk factors in human populations.
  • Evaluation of clinical significance and association with lung diseases.

Main Results:

  • Pneumocystis colonization occurs in both animals and diverse human populations.
  • Sensitive molecular methods are key for identifying colonization.
  • Low-level Pneumocystis in the lungs may trigger inflammation and contribute to lung diseases.

Conclusions:

  • Pneumocystis colonization is an emerging clinical consideration.
  • Understanding colonization is crucial for managing lung inflammation and disease in at-risk individuals.
  • Further research is needed to fully elucidate the clinical impact of Pneumocystis colonization.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.